Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Invested Capital (2016 - 2025)

Historic Invested Capital for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $61.7 million.

  • Xtant Medical Holdings' Invested Capital rose 525.32% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.7 million, marking a year-over-year increase of 525.32%. This contributed to the annual value of $55.1 million for FY2024, which is 158.65% down from last year.
  • Per Xtant Medical Holdings' latest filing, its Invested Capital stood at $61.7 million for Q3 2025, which was up 525.32% from $60.5 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Invested Capital ranged from a high of $61.7 million in Q3 2025 and a low of $31.9 million during Q2 2022
  • In the last 5 years, Xtant Medical Holdings' Invested Capital had a median value of $47.4 million in 2023 and averaged $46.9 million.
  • The largest annual percentage gain for Xtant Medical Holdings' Invested Capital in the last 5 years was 18101.28% (2021), contrasted with its biggest fall of 2470.98% (2021).
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Invested Capital stood at $34.5 million in 2021, then grew by 27.11% to $43.9 million in 2022, then rose by 27.62% to $56.0 million in 2023, then fell by 1.59% to $55.1 million in 2024, then grew by 12.0% to $61.7 million in 2025.
  • Its Invested Capital stands at $61.7 million for Q3 2025, versus $60.5 million for Q2 2025 and $55.1 million for Q1 2025.